New: Fluorescent 3D tumor microtissues
In May, InSphero, in collaboration with Sirion Biotech, Germany, launched a new product family that makes oncology drug testing using 3D microtissues much easier: our assay-ready, fluorescent 3D microtissues can be directly read out using fluorescence plate readers. More information on this new product here.
Fluorescent tumor co-culture of HCT116 (green) and NIH3T3 fibroblast cells (red)
New application note with Tecan: Analyzing biological drug effects in 3D
Together with our partners Tecan and Sirion Biotech we show how 3D microtissues with implemented fluorescence reporter proteins can be used to verify drug sensitivity and to better understand biological mechanistics. More information and the full application note can be found here.
Workshop on 3D cell culture, June 11 in Zurich - Registeration deadline soon!
InSphero's next European Customer Workshop will bring together international experts on 3D cell culture:
An in-depth introduction to 3D microtissues and applications
NEW: For experienced microtissue users - hands-on labs and lectures on advanced topics including histology and 3D biochemical assays (session runs parallel to the introductory 3D cell culture talks).
NEW: Presentations from industrial and academic users of 3D microtissues about results and applications.
This full-day event will be held in Zurich, Switzerland on June 11, 2012, starting at 8:30am. View the final program or register by e-mail now! Please register by May 31 to assure your participation.
InSphero workshop in Copenhagen, Denmark, Feb 2012
3D cell culture literature picks – May 2012
Our applications team has reviewed a small selection of current 3D-cell-culture journal papers this month to keep you up-to-date about recent developments in 3D.
New USA Sales Manager
With InSphero's business growing rapidly in the USA, Davina Heller has joined the company as our new USA Sales Manager. She resides in San Diego and covers the Western and Midwestern states. Read more here.
Meet the InSphero team at upcoming fairs, conferences and workshops to learn how scaffold-free organotypic 3D microtissues, and 3D optimized assays, accelerate the process of drug discovery and development.
